久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/03/01 | 7,690 | 7,690 | 7,510 | 7,530 | -210 | -2.7% | 125,000 |
2018/02/28 | 7,790 | 7,840 | 7,720 | 7,740 | -50 | -0.6% | 180,500 |
2018/02/27 | 7,720 | 7,840 | 7,630 | 7,790 | +80 | +1% | 203,200 |
2018/02/26 | 7,340 | 7,780 | 7,330 | 7,710 | +480 | +6.6% | 219,200 |
2018/02/23 | 7,360 | 7,360 | 7,210 | 7,230 | -130 | -1.8% | 116,300 |
2018/02/22 | 7,250 | 7,420 | 7,250 | 7,360 | -30 | -0.4% | 117,600 |
2018/02/21 | 7,350 | 7,470 | 7,290 | 7,390 | +40 | +0.5% | 104,000 |
2018/02/20 | 7,310 | 7,390 | 7,270 | 7,350 | +30 | +0.4% | 107,400 |
2018/02/19 | 7,320 | 7,370 | 7,230 | 7,320 | ±0 | ±0% | 101,600 |
2018/02/16 | 7,200 | 7,390 | 7,200 | 7,320 | +210 | +3% | 119,000 |
2018/02/15 | 7,150 | 7,220 | 7,080 | 7,110 | +30 | +0.4% | 127,900 |
2018/02/14 | 7,100 | 7,130 | 7,030 | 7,080 | -20 | -0.3% | 134,200 |
2018/02/13 | 7,310 | 7,320 | 7,070 | 7,100 | -140 | -1.9% | 171,900 |
2018/02/09 | 7,150 | 7,240 | 7,110 | 7,240 | -100 | -1.4% | 110,500 |
2018/02/08 | 7,360 | 7,470 | 7,320 | 7,340 | -20 | -0.3% | 155,800 |
2018/02/07 | 7,390 | 7,620 | 7,360 | 7,360 | +120 | +1.7% | 163,800 |
2018/02/06 | 7,330 | 7,390 | 7,150 | 7,240 | -430 | -5.6% | 222,800 |
2018/02/05 | 7,630 | 7,740 | 7,610 | 7,670 | -100 | -1.3% | 144,500 |
2018/02/02 | 7,730 | 7,800 | 7,690 | 7,770 | -20 | -0.3% | 112,700 |
2018/02/01 | 7,510 | 7,800 | 7,490 | 7,790 | +290 | +3.9% | 193,300 |
2018/01/31 | 7,630 | 7,690 | 7,490 | 7,500 | -200 | -2.6% | 208,400 |
2018/01/30 | 7,770 | 7,770 | 7,660 | 7,700 | -80 | -1% | 124,200 |
2018/01/29 | 7,800 | 7,840 | 7,750 | 7,780 | +20 | +0.3% | 121,300 |
2018/01/26 | 7,760 | 7,810 | 7,720 | 7,760 | +80 | +1% | 159,400 |
2018/01/25 | 7,560 | 7,720 | 7,560 | 7,680 | +30 | +0.4% | 135,500 |
2018/01/24 | 7,640 | 7,670 | 7,580 | 7,650 | +50 | +0.7% | 108,000 |
2018/01/23 | 7,550 | 7,670 | 7,530 | 7,600 | +120 | +1.6% | 142,500 |
2018/01/22 | 7,300 | 7,480 | 7,300 | 7,480 | +220 | +3% | 142,000 |
2018/01/19 | 7,280 | 7,290 | 7,190 | 7,260 | -10 | -0.1% | 123,800 |
2018/01/18 | 7,470 | 7,470 | 7,250 | 7,270 | -140 | -1.9% | 139,900 |
2018/01/17 | 7,350 | 7,430 | 7,320 | 7,410 | -40 | -0.5% | 162,500 |
2018/01/16 | 7,310 | 7,470 | 7,260 | 7,450 | +110 | +1.5% | 168,000 |
2018/01/15 | 7,060 | 7,360 | 7,000 | 7,340 | +420 | +6.1% | 273,300 |
2018/01/12 | 7,040 | 7,060 | 6,900 | 6,920 | -90 | -1.3% | 146,300 |
2018/01/11 | 7,090 | 7,110 | 6,950 | 7,010 | -80 | -1.1% | 132,700 |
2018/01/10 | 7,070 | 7,100 | 7,040 | 7,090 | +10 | +0.1% | 95,200 |
2018/01/09 | 7,110 | 7,130 | 7,040 | 7,080 | -60 | -0.8% | 87,100 |
2018/01/05 | 7,100 | 7,140 | 7,040 | 7,140 | +80 | +1.1% | 122,400 |
2018/01/04 | 6,930 | 7,060 | 6,910 | 7,060 | +230 | +3.4% | 129,400 |
2017/12/29 | 6,800 | 6,890 | 6,770 | 6,830 | +30 | +0.4% | 82,800 |
2017/12/28 | 6,820 | 6,880 | 6,780 | 6,800 | ±0 | ±0% | 68,500 |
2017/12/27 | 6,860 | 6,860 | 6,770 | 6,800 | ±0 | ±0% | 56,100 |
2017/12/26 | 6,700 | 6,890 | 6,570 | 6,800 | -80 | -1.2% | 195,400 |
2017/12/25 | 6,810 | 6,890 | 6,780 | 6,880 | +110 | +1.6% | 92,900 |
2017/12/22 | 6,660 | 6,770 | 6,600 | 6,770 | +100 | +1.5% | 141,300 |
2017/12/21 | 6,630 | 6,670 | 6,570 | 6,670 | +80 | +1.2% | 84,100 |
2017/12/20 | 6,550 | 6,630 | 6,550 | 6,590 | +20 | +0.3% | 78,700 |
2017/12/19 | 6,600 | 6,650 | 6,550 | 6,570 | -20 | -0.3% | 142,700 |
2017/12/18 | 6,540 | 6,650 | 6,510 | 6,590 | +100 | +1.5% | 152,000 |
2017/12/15 | 6,540 | 6,540 | 6,470 | 6,490 | -60 | -0.9% | 165,800 |
1751~
1800
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム